William Davis, DO
Sports Medicine · Indianapolis, INNPI 1497195697
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,542 of the $2,326 with a category attached, or 66.3%. 19 manufacturers reported payments, led by Alpha Orthopedic Systems at 49.0% of the total. Reporting peaked in 2020 at $1,503 and has fallen 97.2% since, to $41 in 2024.
Across 89 payments — averaging $26.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alpha Orthopedic Systems$1K
- Pacira Therapeutics, Inc.$361
- Amgen$219
- Sanofi-aventis U.S. LLC$133
- Arthrex$90
- Radius Health, Inc.$89
- plus $294 from 13 others
What the payments were for
- Travel & lodging$78434%
- Food & beverage$1,54266%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alpha Orthopedic Systems | 13 | $1,140 |
| Pacira Therapeutics, Inc. | 29 | $361 |
| Amgen(2 entities) | 14 | $219 |
| Sanofi-aventis U.S. LLC | 7 | $133 |
| Arthrex | 2 | $90 |
| Radius Health, Inc. | 6 | $89 |
| Johnson & Johnson(2 entities) | 3 | $45 |
| AstraZeneca | 2 | $33 |
| Bioventus LLC | 2 | $31 |
| Hydrocision, Inc. | 1 | $27 |
| Zimmer Biomet | 1 | $26 |
| Onkos Surgical, Inc. | 1 | $25 |
| AbbVie(2 entities) | 2 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Acera Surgical, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $9 |
How this compares
$2,326 in reported general payments places this provider in the 70th percentile of 156 sports medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 186 | $705 |
| Ibuprofen | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Indianapolis
- Nedal AlkhatibIndianapolis$51K
- David FoulkIndianapolis$21K
- Andrew GudemanIndianapolis$17K
- Patrick SiparskyIndianapolis$16K
- Kevin GebkeIndianapolis$14K
- Christopher DefalcoIndianapolis$11K
- Steven AhlfeldIndianapolis$10K
- Troy RobersonIndianapolis$4K
- Evan ArmingtonIndianapolis$2K
- Gregory EstesIndianapolis$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.